Middle East And Africa Fluorspot And Elispot Assay Market
市场规模（十亿美元）
CAGR :
% 
USD
11.04 Million
USD
22.10 Million
2020
2028
 Forecast Period |
2021 –2028 |
 Market Size (Base Year) |
USD 11.04 Million |
 Market Size (Forecast Year) |
USD 22.10 Million |
 CAGR |
% |
| Major Markets Players |
中东和非洲 ELISpot 和 FluoroSpot 检测市场，按产品类型（检测试剂盒、分析仪、补充或辅助产品）、按来源（人类、小鼠、猴子和其他）、按疾病（传染病、癌症、自身免疫性疾病、过敏和其他）、按应用（诊断应用、研究应用）、按最终用户（医院和临床实验室、研究机构、生物制药公司和其他）、按分销（直接招标、零售销售）、国家（南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区）划分的市场趋势和预测到 2028 年。
市场分析和见解：中东和非洲 ELISpot 和 FluoroSpot 检测市场
中东和非洲 ELISpot 和 FluoroSpot 检测市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2021 年至 2028 年的预测期内，该市场以 8.7% 的复合年增长率增长，预计到 2028 年将从 2020 年的 1104 万美元增至 2210 万美元。
酶联免疫斑点 (ELISpot) 检测法灵敏度高，广泛应用于诊断各种疾病。它非常灵活，常用于测量小鼠和人类的抗原特异性 T 细胞。这些测试最近最受欢迎，而且非常流行，因为它们能够测量广泛的免疫反应和细胞免疫相关活动。因此，现在 ELISpot 已从一种研究工具转变为实验室中广泛使用的临床检测方法。各种形式的 ELISpot 检测法，如 IFN-gamma ELISpot、Granzyme B ELISpot、TGF-Beta 1 ELISpot、荧光 ELISpot 等，已用于多种诊断应用。FluoroSpot 检测法采用夹心检测原理，将单克隆抗体与 PVDF 膜的混合物放入 96 孔板中进行检测。ELISpot 和 FluoroSpot 广泛适用于分泌蛋白，如来自活化细胞的细胞因子。
慢性病发病率的上升、对及时诊断疾病的认识的提高以及 FluorSpot 检测的普及为 ELISpot 和 FluorSpot 检测市场的增长铺平了道路。此外，新兴经济体医疗支出的增长潜力也推动了 ELISpot 和 FluorSpot 检测市场的增长。然而，成本上升、高质量检测试剂的供应不足、发展中国家无法获得 ELISpot 和 FluorSpot 检测是阻碍市场增长的制约因素。进行诊断测试时面临的操作障碍、所用材料的不一致以及市场参与者之间日益激烈的竞争是阻碍市场增长的挑战。
ELISpot 和 FluoroSpot 检测市场报告提供了市场份额、新发展和产品线分析的详细信息，国内和本地市场参与者的影响，分析了新兴收入领域、市场法规变化、产品批准、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报。我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
中东和非洲 ELISpot 和 FluoroSpot 检测市场范围和市场规模
ELISpot 和 FluoroSpot 检测市场根据产品类型、来源、疾病、应用、最终用户和分销进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
- 根据产品类型，ELISpot 和 FluorSpot 检测市场分为检测试剂盒、分析仪、补充或辅助产品。2021 年，检测试剂盒部分预计将在 ELISpot 和 FluorSpot 检测市场中占据主导地位，因为药物研发中对基于细胞的检测的偏好日益增加，癌症研究中也开始使用 T 细胞检测。
- 根据来源，ELISpot 和 FluorSpot 检测市场分为人类、小鼠、猴子和其他。2021 年，由于易于检测血液样本中的细胞因子以检测慢性疾病，预计人类将主导 ELISpot 和 FluorSpot 检测市场。
- 根据疾病，ELISpot和FluorSpot 检测市场细分为传染病、 癌症、自身免疫性疾病、过敏等。2021 年，由于慢性传染病数量不断增加，以及人们对使用 ELISpot 和 FluorSpot 检测的认识不断提高，预计传染病领域将主导 ELISpot 和 FluorSpot 检测市场。
- 根据应用，ELISpot 和 FluorSpot 检测市场细分为诊断和研究应用。由于慢性传染病数量不断增加，以及疫情期间即时诊断的使用，预计 2021 年诊断应用领域将主导 ELISpot 和 FluorSpot 检测市场。
- 根据最终用户，ELISpot 和 FluorSpot 检测市场分为医院和诊所、研究机构、生物制药公司和其他。由于诊断基础设施增强和医疗保险政策的推出，预计 2021 年医院和诊所将主导 ELISpot 和 FluorSpot 检测市场。
- 根据分销情况，ELISpot 和 FluorSpot 检测市场分为直接招标和零售销售。2021 年，直接招标市场预计将在 ELISpot 和 FluorSpot 检测市场占据主导地位，因为直接招标市场可以获得更多联系人、节约更多成本，并确保合规参与。
中东和非洲 ELISpot 和 FluoroSpot 检测市场国家级分析
对 ELISpot 和 FluoroSpot 检测市场进行了分析，并按产品和服务、样品类型、流程、应用、化合物库大小、最终用户和分销渠道提供了市场规模信息
中东和非洲 ELISpot 和 FluoroSpot 检测市场报告涵盖的国家包括南非、沙特阿拉伯、阿联酋、埃及、以色列以及中东和非洲其他地区。
预计在 2020 年至 2028 年的预测期内，中东和非洲将以可观的增长率增长，因为中东和非洲国家是主要的发展中国家，并且专注于增加制药和生物技术领域的研发活动并增加外包服务。预计南非将在中东和非洲市场占据主导地位。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了中东和非洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战，销售渠道的影响。
ELISpot 和 FluoroSpot 检测在新兴经济体的增长潜力以及市场参与者的战略举措正在为中东和非洲 ELISpot 和 FluoroSpot 检测市场创造新的机遇。
ELISpot 和 FluoroSpot 检测市场还为您提供每个国家/地区特定行业 ELISpot 和 FluoroSpot 检测销售增长的详细市场分析、ELISpot 和 FluoroSpot 检测发展的影响以及监管情景的变化及其对中东和非洲 ELISpot 和 FluoroSpot 检测市场的支持。数据涵盖 2010 年至 2019 年的历史时期
竞争格局和 中东 及非洲 ELISpot 和 FluoroSpot 检测市场份额分析
中东和非洲 ELISpot 和 FluoroSpot 检测市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对 ELISpot 和 FluoroSpot 检测市场的关注有关。
提供中东和非洲 ELISpot 和 FluoroSpot 检测的主要公司有 BD、R&D Systems, Inc.、CellCarta、DIACLONE SAS、Abcam plc、Covance Inc.、Cellular Technology Ltd、U-CyTech、Oxford Immunotec USA, Inc.、Bio-Connect Diagnostics BV 等。
市场参与者的战略举措以及 ELISpot 和 FluoroSpot 检测的新技术进步正在弥合慢性伤口治疗方面的差距。
例如，
- 2021 年 6 月，DIACLONE SAS 组织了第 9 届 2021 年抗体工业研讨会 (AIS2021)。该公司与科学协会 LabEx MAbImprove 和工业组织 MabDesign 于 2021 年 6 月 22 日至 25 日共同组织了此次研讨会。该公司展示了其产品组合。网络研讨会将提高人们对抗体在 ELISpot 和 Fluorospot 检测中的新用途的认识。这些抗体还将用于 COVID-19 疫苗研究。
市场参与者的合作、合资和其他策略正在增强公司在中东和非洲 ELISpot 和 FluoroSpot 检测市场的市场，这也为该组织改善其治疗产品供应提供了好处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 PORTERS FIVES FORCES
6 PESTEL ANALYSIS
7 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: REGULATIONS
7.1 REGULATION IN THE U.S.
7.2 REGULATION IN EUROPE:
7.3 REGULATIONS IN CHINA
7.4 MEDICAL DEVICE INSTRUCTIONS:
7.5 REGULATIONS IN JAPAN
7.6 REGULATION IN INDIA
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 INCREASED INCIDENCE OF CHRONIC DISEASES
8.1.2 SURGE IN AWARENESS ABOUT THE TIMELY DIAGNOSIS OF THE DISEASE
8.1.3 INCREASED IMPLEMENTATION OF FLUOROSPOT ASSAY
8.1.4 USE OF KITS FOR VACCINE RESEARCH TO OVERCOME THE DRUG RESISTANCE
8.1.5 USE OF ELISPOT AND FLUOROSPOT ASSAY FOR CLINICAL TRIALS
8.2 RESTRAINTS
8.2.1 RISE IN COST OF THE ELISPOT AND FLUOROSPOT DETECTION KITS
8.2.2 AVAILABILITY OF ALTERNATE DETECTION KITS
8.2.3 LESS AVAILABILITY OF HIGH-QUALITY DETECTION REAGENTS
8.2.4 COMPLEXITY IN ELISPOT AND FLUOROSPOT ASSAY
8.3 OPPORTUNITIES
8.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
8.3.2 RISING NUMBER OF IN-VITRO DIAGNOSTIC TESTS
8.3.3 RISING HEALTHCARE EXPENDITURE
8.3.4 INCREASING RESEARCH AND DEVELOPMENT
8.4 CHALLENGES
8.4.1 STRINGENT RULES & REGULATIONS
8.4.2 OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTIC TESTS
8.4.3 RISING COMPETITION BETWEEN MARKET PLAYERS
9 IMPACT OF COVID-19 ON THE MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET
9.1 IMPACT ON PRICE
9.2 IMPACT ON DEMAND
9.3 IMPACT ON SUPPLY CHAIN
9.4 STRATEGIC DECISIONS BY MANUFACTURERS
9.5 CONCLUSION
10 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE
10.1 OVERVIEW
10.2 ASSAY KIT
10.2.1 T-CELL ASSAY
10.2.2 B-CELL ASSAY
10.3 SUPPLEMENTARY/ANCILLARY PRODUCTS
10.4 ANALYZERS
11 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE
11.1 OVERVIEW
11.2 HUMAN
11.3 MOUSE
11.4 MONKEY
11.5 OTHERS
12 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE
12.1 OVERVIEW
12.2 INFECTIOUS DISEASE
12.2.1 INFLUENZA
12.2.2 HIV
12.2.3 COVID-19
12.2.4 OTHERS
12.3 CANCER
12.4 AUTOIMMUNE DISEASE
12.5 ALLERGY
12.6 OTHER
13 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION
13.1 OVERVIEW
13.2 DIAGNOSTIC APPLICATION
13.2.1 INFECTIOUS DISEASES
13.2.2 TRANSPLANTS
13.2.3 OTHERS
13.3 RESEARCH APPLICATION
13.3.1 CLINICAL TRIALS
13.3.2 CANCER RESEARCH
13.3.3 VACCINE DEVELOPMENT
13.3.4 OTHERS
14 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER
14.1 OVERVIEW
14.2 HOSPITALS & CLINICAL LABORATORIES
14.3 RESEARCH INSTITUTES
14.4 BIOPHARMACEUTICAL COMPANIES
14.5 OTHERS
15 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 RETAIL SALES
15.3 DIRECT TENDER
16 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION
16.1 MIDDLE EAST AND AFRICA
16.1.1 SOUTH AFRICA
16.1.2 SAUDI ARABIA
16.1.3 U.A.E
16.1.4 ISRAEL
16.1.5 EGYPT
16.1.6 REST OF MIDDLE EAST AND AFRICA
17 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
18 SWOT ANALYSIS
19 COMPANY PROFILE
19.1 BD
19.1.1 COMPANY SNAPSHOT
19.1.2 REVENUE ANALYSIS
19.1.3 COMPANY SHARE ANALYSIS
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT DEVELOPMENTS
19.2 OXFORD IMMUNOTEC USA, INC. (A SUBSIDIARY OF PERKINELMER INC.)
19.2.1 COMPANY SNAPSHOT
19.2.2 REVENUE ANALYSIS
19.2.3 COMPANY SHARE ANALYSIS
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT DEVELOPMENTS
19.3 R&D SYSTEMS, INC.
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENTS
19.4 MABTECH
19.4.1 COMPANY SNAPSHOT
19.4.2 COMPANY SHARE ANALYSIS
19.4.3 PRODUCT PORTFOLIO
19.4.4 RECENT DEVELOPMENTS
19.5 THERMO FISHER SCIENTIFIC INC.
19.5.1 COMPANY SNAPSHOT
19.5.2 REVENUE ANALYSIS
19.5.3 COMPANY SHARE ANALYSIS
19.5.4 PRODUCT PORTFOLIO
19.5.5 RECENT DEVELOPMENTS
19.6 ABCAM PLC
19.6.1 COMPANY SNAPSHOT
19.6.2 REVENUE ANALYSIS
19.6.3 PRODUCT PORTFOLIO
19.6.4 RECENT DEVELOPMENTS
19.7 AUTOIMMUN DIAGNOSTIKA GMBH
19.7.1 COMPANY SNAPSHOT
19.7.2 PRODUCT PORTFOLIO
19.7.3 RECENT DEVELOPMENT
19.8 CELLCARTA
19.8.1 COMPANY SNAPSHOT
19.8.2 PRODUCT PORTFOLIO
19.8.3 RECENT DEVELOPMENTS
19.9 CELLULAR TECHNOLOGY LIMITED (CTL)
19.9.1 COMPANY SNAPSHOT
19.9.2 PRODUCT PORTFOLIO
19.9.3 RECENT DEVELOPMENT
19.1 COVANCE INC. (A SUBSIDIARY OF LABCORP DRUG DEVELOPMENT)
19.10.1 COMPANY SNAPSHOT
19.10.2 REVENUE ANALYSIS
19.10.3 PRODUCT PORTFOLIO
19.10.4 RECENT DEVELOPMENT
19.11 COVALAB, INC.
19.11.1 COMPANY SNAPSHOT
19.11.2 PRODUCT PORTFOLIO
19.11.3 RECENT DEVELOPMENTS
19.12 DIACLONE SAS
19.12.1 COMPANY SNAPSHOT
19.12.2 PRODUCT PORTFOLIO
19.12.3 RECENT DEVELOPMENTS
19.13 MIKROGEN GMBH
19.13.1 COMPANY SNAPSHOT
19.13.2 PRODUCT PORTFOLIO
19.13.3 RECENT DEVELOPMENT
19.14 OXFORD BIOSYSTEMS LTD.
19.14.1 COMPANY SNAPSHOT
19.14.2 PRODUCT PORTFOLIO
19.14.3 RECENT DEVELOPMENT
19.15 U-CYTECH
19.15.1 COMPANY SNAPSHOT
19.15.2 PRODUCT PORTFOLIO
19.15.3 RECENT DEVELOPMENT
20 QUESTIONNAIRE
21 RELATED REPORTS
表格列表
TABLE 1 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 2 MIDDLE EAST AND AFRICA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 MIDDLE EAST AND AFRICA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA SUPPLEMENTARY/ANCILLARY PRODUCTS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA ANALYZERS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA HUMAN IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA MOUSE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA MONKEY IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA OTHERS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA CANCER IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA AUTOIMMUNE DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA ALLERGY IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA OTHER IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA HOSPITALS & CLINICAL LABORATORIES IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA RESEARCH INSTITUTES IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA BIOPHARMACEUTICAL COMPANIES IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA OTHERS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA RETAIL SALES IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA DIRECT TENDER IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAYMARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION)
TABLE 42 SOUTH AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 43 SOUTH AFRICA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 44 SOUTH AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 45 SOUTH AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 46 SOUTH AFRICA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 47 SOUTH AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 48 SOUTH AFRICA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 49 SOUTH AFRICA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 50 SOUTH AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 51 SOUTH AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION)
TABLE 52 SAUDI ARABIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 53 SAUDI ARABIA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 54 SAUDI ARABIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 55 SAUDI ARABIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 56 SAUDI ARABIA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 57 SAUDI ARABIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 58 SAUDI ARABIA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 59 SAUDI ARABIA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 60 SAUDI ARABIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 61 SAUDI ARABIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION)
TABLE 62 U.A.E ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 63 U.A.E ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 64 U.A.E ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 65 U.A.E ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 66 U.A.E INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 67 U.A.E ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 68 U.A.E DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 69 U.A.E RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 70 U.A.E ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 71 U.A.E ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION)
TABLE 72 ISRAEL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 73 ISRAEL ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 74 ISRAEL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 75 ISRAEL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 76 ISRAEL INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 77 ISRAEL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 78 ISRAEL DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 79 ISRAEL RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 80 ISRAEL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 81 ISRAEL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION)
TABLE 82 EGYPT ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 83 EGYPT ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 84 EGYPT ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 85 EGYPT ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 86 EGYPT INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 87 EGYPT ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 88 EGYPT DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 89 EGYPT RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 90 EGYPT ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 91 EGYPT ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION)
TABLE 92 REST OF MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
图片列表
FIGURE 1 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: SEGMENTATION
FIGURE 11 INCREASED INCIDENCE OF CHRONIC DISEASES AND SURGE IN AWARENESS ABOUT THE TIMELY DIAGNOSIS OF THE DISEASES ARE EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 ASSAY KITS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET
FIGURE 14 PREVALENCE OF CHRONIC DISEASES DURING THE COVID-19 PANDEMIC
FIGURE 15 MIDDLE EAST AND AFRICA INCIDENCE OF KAWASAKI SYNDROME PER 100,000 CHILDREN UNDER 5 YEARS OF AGE
FIGURE 16 INCIDENCE OF CANCER, WHICH INCREASES WITH AGE
FIGURE 17 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE, 2020
FIGURE 18 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE, 2019-2028 (USD MILLION)
FIGURE 19 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 20 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 21 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY SOURCE, 2020
FIGURE 22 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY SOURCE, 2019-2028 (USD MILLION)
FIGURE 23 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY SOURCE, CAGR (2021-2028)
FIGURE 24 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY SOURCE, LIFELINE CURVE
FIGURE 25 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISEASE, 2020
FIGURE 26 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISEASE, 2019-2028 (USD MILLION)
FIGURE 27 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISEASE, CAGR (2021-2028)
FIGURE 28 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISEASE, LIFELINE CURVE
FIGURE 29 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY APPLICATION, 2020
FIGURE 30 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY APPLICATION, 2019-2028 (USD MILLION)
FIGURE 31 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 32 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 33 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY END USER, 2020
FIGURE 34 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY END USER, 2019-2028 (USD MILLION)
FIGURE 35 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY END USER, CAGR (2021-2028)
FIGURE 36 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY END USER, LIFELINE CURVE
FIGURE 37 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 38 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
FIGURE 39 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 40 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 41 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: SNAPSHOT (2020)
FIGURE 42 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2020)
FIGURE 43 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2021 & 2028)
FIGURE 44 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2020 & 2028)
FIGURE 45 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE (2021-2028)
FIGURE 46 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: COMPANY SHARE 2020 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
